GSK

NYSE: GSK · Real-Time Price · USD
39.22
0.09 (0.23%)
At close: Aug 14, 2025, 3:59 PM
38.88
-0.87%
Pre-market: Aug 15, 2025, 07:05 AM EDT

GSK Cash Flow Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
2.95B 4.93B 4.92B 5.1B
Depreciation & Amortization
2.55B 2.29B 2.3B 2.52B
Stock-Based Compensation
344M 307M 346M 343M
Other Working Capital
2.04B 247M 662M 435M
Other Non-Cash Items
-1.38B 945M 351M 756M
Deferred Income Tax
n/a -865M -784M -318M
Change in Working Capital
2.09B -841M 271M -473M
Operating Cash Flow
6.55B 6.77B 7.4B 7.95B
Capital Expenditures
-2.98B -2.34B -2.26B -2.93B
Cash Acquisitions
1.37B -1.47B -3.14B 185M
Purchase of Investments
n/a n/a -144M 1.76B
Sales Maturities Of Investments
21M 72M 1M 18M
Other Investing Acitivies
-1.22B 1.11B -3.23B -808M
Investing Cash Flow
-1.23B -1.59B -8.77B -1.78B
Debt Repayment
-1.17B -2.37B -771M -2B
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-2.44B -2.25B -3.47B -4B
Other Financial Acitivies
-1.14B -1.03B 5.06B -1.61B
Financial Cash Flow
-4.73B -5.64B 823M -7.59B
Net Cash Flow
545M -567M -394M -1.44B
Free Cash Flow
3.57B 4.42B 5.14B 5.02B